Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIC: ADVATE in Hemophilia A
NCT01376700Phase 3Terminated
- Sponsor
- Takeda
- Start
- Aug 2011
- Primary completion
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
A Phase 3 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Takeda. Started Aug 2011; status: terminated.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01376700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01376700.